abrysvo: Clinical Trials

3 trials of abrysvo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Recruiting 2, Completed 1

Follow abrysvo: new trials by email Literature Review of abrysvo trials Research Report on abrysvo

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
Tdap Vaccine Administration, RSV Vaccine, Saline (as a placebo) - RSV, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination
Phase 4RecruitingCanadian Immunization Research Network602025-10-162026-10-22
The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products
Abrysvo, Beyfortus - Respiratory Syncytial Virus Infection
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1812024-09-192026-05-11
Vaccine Responses in Patients With B Cell Malignancies
AREXVY, ABRYSVO, PREVNAR 20, PNEUMOVAX 23 - Lymphoma
Phase 4RecruitingNational Heart, Lung, and Blood Institute (NHLBI)3502022-09-142026-08-04

Conditions studied

Diphtheria (1)  ·  Lymphoma (1)  ·  Respiratory Syncytial Virus Infections (1)

Sponsors

Canadian Immunization Research Network (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Adrian U Wiestner, M.D. (1)  ·  Bahaa Abu-Raya, M.D., PhD (1)

NIH funding

5UM1AI148684-04 (1)